Investigation of selective glucocorticoid receptor modulation in high-grade serous ovarian cancer PDX models.

J Gynecol Oncol · 2025 · PMC11790989 · PMID 38909640

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In one of the 6 models, we found that tumor shrinkage following carboplatin (as measured by peritoneal transcutaneous ultrasonography) showed a trend towards improvement with the addition of the SGRM.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.